Therapies

  • Orangutans
    University of Colorado Boulder researchers have discovered that a protein-coding gene called Schlafen11 (SLFN11) may induce a broad-spectrum cellular response against infection by viruses including HIV-1.The new research, which was
  • Loren Hough
    Tubulin, a protein found in your cells, quietly lends itself to many life processes. It sorts itself into long chains, forming tubes that provide scaffolding for living cells. A versatile shapeshifter, tubulin can arrange itself into different
  • Tom Cech's lab is focused, in part, on studying telomerase: a powerful enzyme found at the ends of chromosomes.
     A deep look inside the live cells reveals a key cancer process Telomerase, a powerful enzyme found at the ends of chromosomes, can keep humans healthy, or promote cancer growth. Researchers at the University of Colorado in Boulder used a
  • BioFrontiers' Aaron Clauset used computer networking techniques to better understand malaria's genetic strategy.
    A new paper published Nature Communications, coauthored by a researcher at the University of Colorado’s BioFrontiers Institute, looked at the genetic strategy used by the human malaria parasite and how old it is from an evolutionary perspective
  • Sara Sawyer recently joined BioFrontiers. Now that the dust is settling in her lab, she's back to focusing on zoonotic diseases.
    New BioFrontiers lab uses evolution to fight diseaseby Paul McDivittPhoto: Sara SawyerEbola comes from bats, HIV from primates, and new strains of influenza from birds and pigs. With zoonotic diseases – those capable of transmission from animals to
  • BioFrontiers Hubert Yin is focused on toll-like receptors that may play a role in new therapies for neurodegenerative diseases.
    If you believe the common adage that you are only using ten percent of your brain, while the other ninety percent remains untapped potential, you are about to be surprised. It’s true that about ten percent of your nervous system is made up of hard-
  • BioFrontiers Hubert Yin is focused on toll-like receptors that may play a role in new cancer therapies.
    BioFrontiers’ Hubert Yin is unlocking the power of toll-like receptorsHubert Yin has been thinking about one type of cell receptor since he joined the BioFrontiers Institute, and it is a receptor worthy of that kind of time. Yin, an Associate
  • Telomeres sit at the ends of chromosomes to protect their genetic data (colorful DNA pic) Credit: Jane Ades, NHGRI
    Among cancers, scientists have spent their entire research careers looking for cellular similarities that may lead to a single cure for many cancers –– the rare chance to have a single answer to a multifaceted problem. In 1997, scientists discovered
  • BioFrontiers' Amy Palmer studies the effects that zinc has on a wide variety of cellular processes.
    Few people think of metals as being vital to our health. Although most people are aware of iron, zinc is just as important, and is involved in a much wider array of biological functions. Ten percent of the proteins used to build our cells, tissues
  • Mary Allen is a postdoc in Robin Dowell's lab at the BioFrontiers Institute.
    Mary Allen holds up a valentine sent to her from a childhood friend. It sits in her cubicle where she is hard at work tearing apart genomic data looking for patterns. This friend, who has Down syndrome, is part of the reason that Allen, a
Subscribe to Therapies